耐药是影响紫杉类药物临床疗效的重要因素。
Drug resistance is the main restriction factor for clinical usage of taxanes.
目前乳腺癌辅助化疗应用最多的仍是蒽环类及紫杉类药物。
Nowaday, the chemotherapeutic drugs of anthracycline and taxane are used widely in breast cancer.
在2个紫杉类药物中，泰素和泰索帝与阿霉素联合均为合理的选择。
Between the two taxanes, both Taxol and Taxotere are reasonable options to combine with Adriamycin for our patient.
应用推荐